LORATADINE TABLETS

The Defense Logistics Agency awarded a delivery order under the base contract SPE2DX-25-D-9900 to DMS PHARMACEUTICAL GROUP INC, identified by CAGE code 1UNB0, for the supply of 20,000 packages of LORATADINE TABLETS with NSN 6505013770448, at a total value of $400.20. The award, issued on July 14, 2026, through delivery order SPE2DP-26-F-7474, constitutes a firm-fixed-price, single-line item procurement with no option quantities or variability in volume. The drug is to be delivered FOB destination to Fort Bragg, North Carolina, by July 29, 2026, with the contractor bearing all transportation costs and risks until delivery. The product must be shipped in packages clearly marked with both the base contract number and delivery order number, and must comply with DLA Unit of Issue standards as referenced in Section B of the contract. Inspection and acceptance occur upon delivery at the destination by an authorized government representative, with no explicit quality or packaging standards beyond marking and tracing requirements. The awardee is a certified Women-Owned Small Business and is subject to FAR 52.219-10 and 52.219-26 reporting obligations, but no other socioeconomic certifications are indicated. Payment will be processed through the Defense Finance and Accounting Service in Columbus, Ohio, using payment code SL4701, and invoicing will follow the government’s voucher system. The contracting officer, Lisa Quinn, and administrative contact Shairy M. Cartagena oversee the order, with no formal COR or COTR named. Although the contract falls under an IDIQ structure, this order represents a standalone, non-modifiable transaction with no indication of future deliveries or flexibility in terms.